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Surgical approachesAbstract Adenoid cystic carcinoma (ACC) of sinonasal is an uncommon tumour that progresses
slowly and generally manifested in advanced stage. Surgical management of sinonasal ACC can be
challenging to the attending surgeon as they need to outweigh the decision between tumour clear-
ance and morbidity of the patient. Multimodality treatment is the mainstay of treatment for sino-
nasal ACC and prognosis depends on the histological subtype of tumour, patient factor and
treatment modalities opted. We are presenting 2 cases of sinonasal ACC manifested in different
age groups in our centre with different types of surgical approaches opted and their outcomes.
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nd/4.0/).1. Introduction
Sinonasal malignancy accounts for 1–2% of all malignancies.
Adenoid cystic carcinoma (ACC) is the 3rd commonest sino-
nasal malignancy. It is common in females compared to maleswith a ratio of 2:1 and the peak incidence at age of 5th to 6th
decade of life. The most common site affected is in the maxil-
lary sinus followed by nasal cavity.1 Tumors of the sinonasal
tract commonly present with symptoms that are identical to
those caused by inflammatory sinus disease, such as nasal
obstruction, nasal discharge, epistaxis, headache, facial pain
and cheek swelling.
ACC exhibits extensive local tissue infiltration and perineu-
ral spread, which results in a high rate of recurrence despite
aggressive surgical resection. Classically, ACC has a distinct
natural history of slow and indolent growth with late develop-
ment of distant metastasis but tends to have local recurrence.2
A few studies suggested that subtype of histopathology of
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determine the prognosis of the survival of a patient.
In general, tumours with perineural invasion, cervical
lymph node metastasis, solid histological features and distant
metastasis are associated with increased treatment failures
and recurrences.3 Tumour stage according to TNM staging
has a significant correlation to the type of modality treatment
opted.4 In view of these tumours being rare and often present-
ing at an advanced stage, controversies exist as to the most
appropriate treatment suitable. Until today, most sources
agree that aggressive treatment of these tumours is necessary.
Radiation therapy (RT), surgical resection, and combined
modality treatments of these tumours have been reported
and suggested.Figure 1 Soft tissue heterogenous enhancement lesion at
anterior left nasal cavity causing mild nasal septum deviation to
the right. There was heterogenous enhancement seen post contrast
and no soft tissue mucosal thickening seen at bilateral maxillary,
ethmoidal, frontal and sphenoid sinuses. There was no turbinate
hypertrophy, bilateral osteomeatal complexes are patent, orbit
and visualized brain is normal. No bony destruction seen.
Figure 2 Tumour cells are predominantly in solid nest (60%)
and cribriform pattern (40%).2. Case report
2.1. Case 1
A 23 year-old Malay lady presented with left epistaxis for
8 months. There was no haematemesis and anaemic symp-
toms. It was associated with persistent left unilateral nasal
obstruction associated gradual painless worsening left cheek
disfigurement for 2 months. There were no allergic rhinitis
symptoms and smell disorder. There was no cheek numbness,
loosening of teeth, blurring of vision, or limited mouth open-
ing. There were also no headache, throat or ear symptoms
and no associated constitutional symptoms.
Generally patient was stable. There was blunted left nasola-
bial fold with vague mass overlying it. All cranial nerves exam-
inations were unremarkable. The nasoendoscope examinations
revealed a mass in the left nasal cavity which were dry, friable
and bleed easily. The mass was sandwiched in between the sep-
tum and lateral nasal wall. Otherwise, the right nasal cavity
was normal and both the Fossa of Rosenmueller (FOR) was
clear.
Computed tomography (CT) scan revealed a soft tissue
lesion at anterior left nasal cavity causing mild nasal septum
deviation to the right. There was heterogenous enhancement
seen post contrast and no soft tissue mucosal thickening seen
at bilateral maxillary, ethmoidal, frontal and sphenoid sinuses
without bony destruction. There was no turbinate hypertro-
phy, bilateral osteomeatal complexes are patent (Fig. 1). There
were no neck nodes or distant metastases.
Magnetic resonance (MRI) scan showed a well-defined
enhancing mass occupying the anterior aspect of left nasal cav-
ity with a tiny hypointense lesion with no enhancement on
post-gadolinium T2 weighted image. There was evidence of
deep aspect of the overlying nasal ala subcutaneous tissues
involvement but preservation superficial subcutaneous fat
and skin of the nasal ala. No enhancing flow void was seen
within the mass to suggest for an enlarged vessels within.
The mass is in contact with the nasal septum. There was min-
imal focal deviation of the nasal septum to the right. There was
no extension to the paranasal sinuses or focal intracranial
lesion. There was no perineural invasion.
Biopsy of the mass revealed multiple fragment of tumour
tissues, a few of the fragments are lined by stratified squamous
epithelium. The tumour cells are predominantly in solid nest
(60%) and cribriform pattern (40%). It is composed of small
basaloid cells with scanty cytoplasm. Mitosis is frequentlyseen. The lumina contain PAS positive materials that are sug-
gestive of adenoid cystic carcinoma (Fig. 2). All blood investi-
gations were in normal range.
Prior surgery, disease was at stage T3N0M0. Patient under-
went tumour resection via combined endoscopic and midfacial
degloving, with sublabial incision approach and transfixes inci-
sion at interseptal cartilage under general anaesthesia. Intraop-
erative revealed a mass arised from the anterosuperior septum
which was about 1 cm anterior to middle meatus. Both infe-
rior, middle turbinate and OMC were normal. The mucosa
of septal cartilage and nasolabial fold which are infiltrated
by the mass are resected. Histopathological (HPE) specimen
revealed a positive margin of tumour septal root, septal
mucosa and nasolabial subcutaneous tissue. The patient was
finally diagnosed as having ACC of nasal septum. She then
underwent radiotherapy 33 fractions for total 66 Gy. 6 months
after surgery follow up showed no recurrence of local and
regional of disease.
Figure 4 Tumour tissue fragment consists of malignant cells
arranged in cribriform, tubular, cords and solid pattern.
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66 year old Malay gentleman with underlying hypertension ini-
tially presented with persistent unilateral left nasal obstruction
associated with blood-stained foul smelling nasal discharge for
4 months duration. There were no anosmia, facial pain, loos-
ening of tooth and no constitutional symptoms. There was
no gross facial asymmetry. Nasoendoscope examination
revealed a fleshy mass occupying the left nostril with contact
bleeding. The mass seems to be arising from lateral nasal wall.
The right nostril showed normal inferior and middle turbinate
with clear osteomeatal complex and both Fossa of Rosen-
mueller were normal.
CT scan showed mass of homogenous soft tissue attenua-
tion within the left nasal cavity extending into left maxillary
as well as left ethmoidal sinus with impression of sinonasal
polyposis and differential of inverted papilloma or carcinoma
(Fig. 3). CT scan staging showed no sign of locoregional and
distant metastases. Biopsy of the mass came back as ACC with
TNM stage of T2N0M0.
Patient then underwent endoscopic resection of tumour,
near total inferior turbinectomy and middle meatal antros-
tomy under general anesthesia. Intraoperative findings showed
a fungating mass occupying the left nasal cavity, its pedicle
originating from inferior turbinate which easily bleed. There
was also suspicious mass with polypoidal mucosa occupying
left maxillary sinus. The anterior and posterior ethmoid cells
were normal.
Histopathological examination post-operative showed the
tumour tissue fragment consists of malignant cells arranged
in cribriform, tubular, cords and solid pattern. The malignant
cells are composed of two populations of basaloid and pale
cells exhibiting oval to round shaped cells with large hyper-
chromatic nuclei, scanty cytoplasm and some shows prominent
nucleoli (Fig. 4). They are surrounded by desmoplastic stroma,
the tubular lumen contains basophilic material. Lymphovascu-
lar and perineural invasion was not seen. The oncological
tumour margin was clear. The mass in maxillary sinus was
reported as benign inflammatory polyps.
Patient underwent 35 fractions of radiotherapy for total
60 Gy. During follow up 3 months post radiotherapy, thereFigure 3 Homogenous soft tissue attenuation within the left
nasal cavity extending into left maxillary as well as left ethmoidal
sinus.was distorted small stump of the left inferior turbinate with
no local and regional recurrence.
3. Discussion
Adenoid cystic carcinoma is the third commonest sinonasal
malignancy. It posed challenges in term of its management
because of difficulty to access the tumour. Furthermore most
patients at presentation are already at advanced stages of the
disease.5 The earlier the diagnosis and treatment received
patients will have better outcomes in terms of morbidity, risk
of residual or recurrence of disease. A few important factors
that need to be considered in the treatment of sinonasal malig-
nancy are oncological clearance of surgery, functional status of
the patient and cosmetic acceptability.
Clinical manifestation of adenocystic carcinoma varies but
the patient mainly presents with epistaxis and nasal blockage.
As in both cases, its clinical presentation is classical and at an
early stage, there were no symptoms of local spread. Sinonasal
malignancy commonly presented with nasal obstruction, fol-
lowed by epistaxis and local spread symptoms such as audi-
tory, nerve and visual symptoms.6
Surgery is the mainstay of the treatment for sinonasal ACC.
It can be either open, endoscopic or a combined approach. The
current paradigm of treatment of sinonasal malignancy is
towards multimodality and multidisciplinary approaches.7 Ide-
ally, adjuvant chemoradiation is given 4–6 weeks after surgery.
In our first case, the patient is a young female unfortunately
diagnosed at quite moderately advanced stage of the disease;
T3N0M0. Although it was postulated that adenoid cystic car-
cinoma may have distant metastases, but one study showed
that a large tumour of adenoid cystic carcinoma often does
not have distant metastases.8 Therefore, oncological clearance
of surgery is mandatory with preservation of function and cos-
metic acceptability in this patient. She underwent a combined
open and endoscopic midfacial degloving and transfix incision
at interseptal cartilaginous approach. Post operatively, her
HPE showed clear oncological margin of tumour. She then
received post-operative radiotherapy. This is in concordant
with one of the cancer centre experiences in multimodality
treatment for adenoid cystic carcinoma. This centre showed
better outcomes in terms of prognosis in comparison with sin-
gle modality treatments.9
For our second case, patient presented to us at stage
T2N0M0 and underwent endoscopic approach tumour
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Although the study showed perineural and perivascular inva-
sion are high in adenoid cystic carcinoma10, in both our cases
there was no invasion seen from imaging and HPE.
Generally, adenoid cystic carcinoma is associated with
good prognosis in stage I–II of the tumour when combined
with multimodality treatment. There are few factors that give
favourable prognosis of ACC such as histopathological find-
ings of solid type of tumour, absent of perineural or perivascu-
lar invasion, absent of distant metastases, site of tumour as
well as patient and treatment factors such as age and multi-
modality treatment.11 In both of our cases upon follow up
after radiotherapy, there was no local and distant tumour
recurrence.
4. Conclusion
Sinonasal ACC may manifest in various presentations with
peak incidence at 5th to 6th decade of life. However, classical
symptoms of sinonasal ACC are epistaxis, nasal blockage and
cheek swelling. Therefore, any patient with suspicious malig-
nancy needs to be investigated thoroughly by histological diag-
nosis. The mainstay treatment of sinonasal ACC is surgery
followed by radiotherapy. However, option of surgical
approach may tailor to the case basis. Tumour factors such
as tumour stage, locoregional metastasis significantly affect
treatment modalities. Besides that, patient and surgeon factors
also influence the outcome of treatment.
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